TrialEuropean journal of nuclear medicine and molecular imaging2014

¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Pierre-Yves Salaun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.